Gregory Ahmann - Concepedia

Author

Gregory Ahmann

Mayo Clinic in Arizona

Also Known As

G Ahmann, G J Ahmann, G. Ahmann, G. J. Ahmann, GREGORY J. AHMANN, Gregory Ahmann, Gregory J Ahmann, Gregory J. Ahmann

112

Publications

5.7K

Citations

H-Index

Concepts

All Affiliations

Mayo Clinic in Arizona Mayo Clinic WinnMed Translational Genomics Research Institute Multiple Myeloma Research Foundation

About

Gregory Ahmann is an author at Mayo Clinic in Arizona specializing in medicine, pathology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	16	2.5K
2	Immunology	10	10	1.1K
3	Cell Biology	7	7	1.5K
4	Health Sciences	5	5	393
5	Blood Transplantation	1	1	58

Gregory Ahmann

Publications

5.5K

Citations

H-Index

Page 1

	Year	Citations
Initial genome sequencing and analysis of multiple myeloma Michael A. Chapman, Michael S. Lawrence, Jonathan J. Keats, Nature	2011	1.4K
Promiscuous Mutations Activate the Noncanonical NF-κB Pathway in Multiple Myeloma Jonathan J. Keats, Rafaël Fonseca, Marta Chesi, Cancer Cell Hematological MalignancyMedicineCancer Cell BiologyMultiple MyelomaCancer Genetics	2007	980
Genomic abnormalities in monoclonal gammopathy of undetermined significance Rafaël Fonseca, Richard J. Bailey, Gregory Ahmann, Blood	2002	347
The bone marrow of multiple myeloma patients contains B cell populations at different stages of differentiation that are clonally related to the malignant plasma cell. Daniel D. Billadeau, Gregory Ahmann, Patricia T. Greipp, The Journal of Experimental Medicine Mixed-phenotype Acute LeukemiaImmunologyPathologyCh PrimersTumor Biology	1993	241
Waldenstrom macroglobulinemia neoplastic cells lack immunoglobulin heavy chain locus translocations but have frequent 6q deletions Roelandt F.J. Schop, W. Michael Kuehl, Scott A. Van Wier, Blood	2002	202
Systemic therapy of myeloma xenografts by an attenuated measles virus Kah-Whye Peng, Gregory Ahmann, Linh Pham, Blood	2001	181
IAP antagonists induce anti-tumor immunity in multiple myeloma Marta Chesi, Noweeda Mirza, Victoria M. Garbitt, Nature Medicine Cancer ImmunosurveillanceImmunologyTumor ImmunityImmune Checkpoint InhibitorMultiple Myeloma	2016	169
Selective Inhibition of Nuclear Export With Oral Selinexor for Treatment of Relapsed or Refractory Multiple Myeloma Dan T. Vogl, David Dingli, Robert F. Cornell, Journal of Clinical Oncology ImmunologyMyeloma RefractoryPharmacotherapyImmunotherapyTumor Biology	2018	161
Translocations involving the immunoglobulin heavy-chain locus are possible early genetic events in patients with primary systemic amyloidosis Suzanne R. Hayman, Richard J. Bailey, Syed M. Jalal, Blood	2001	138
Prognostic factors for hyperdiploid-myeloma: effects of chromosome 13 deletions and IgH translocations Wee Joo Chng, Rafael Santana-Dávila, Scott A. Van Wier, Leukemia Prognostic FactorsLymphoid NeoplasiaHematological MalignancyMedicineHematology	2006	134

Page 1